Research
Use of Glucagon-Like Peptide-1 Medications and Modified Medication Use Among Adults - United States, 2025
CDC MMWR ·
The Brief
- A CDC Morbidity and Mortality Weekly Report covers GLP-1 medication use among US adults in 2025.
- The report also covers use of compounded GLP-1 medications.
- The provided sources do not include the report's specific figures.
Why it matters
It documents how widely GLP-1 drugs, including compounded versions, were used by American adults, giving researchers a population-level baseline.
Who’s affected
- public health researchers
- US health policy analysts
- #glp-1
- #public health
- #medication use
- #compounded drugs
- #united states
This report describes GLP-1 and compounded GLP-1 use among adults during 2025.
Timeline
MMWR report on GLP-1 use among US adults in 2025 published
Morbidity and Mortality Weekly Report (MMWR)
Use of Glucagon-Like Peptide-1 Medications and Modified Medication Use Among Adults - United States, 2025